Recommendation:
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T he U.S. Preventive Services Task Force (USPSTF) makes
recommendations about the effectiveness of specific preventive care services for patients without related signs or symptoms.
It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment.
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
SUMMARY OF RECOMMENDATIONS AND EVIDENCE
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disease or cancer. (I statement)
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of single-or paired-nutrient supplements (except ␤-carotene and vitamin E) for the prevention of cardiovascular disease or cancer. (I statement) The USPSTF recommends against ␤-carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer. (D recommendation) See the Clinical Considerations section for suggestions for practice regarding the I statements.
See the Figure for a summary of the recommendation and suggestions for clinical practice.
Appendix Table 1 describes the USPSTF grades, and Appendix Table 2 describes the USPSTF classification of levels of certainty about net benefit (both tables are available at www.annals.org).
(1). Supplement use is more common in women and older adults than in men and younger adults (2) . Most dietary supplements are used to improve or maintain overall health (1) . The substantial effect of cardiovascular disease and cancer on health status and mortality in the United States has been well-described (3), and many supplements are promoted to prevent these conditions (4) .
Benefits of Vitamin Supplementation
The USPSTF found inadequate evidence on the benefits of supplementation with multivitamins to reduce the risk for cardiovascular disease or cancer. The USPSTF found inadequate evidence on the benefits of supplementation with individual vitamins or minerals or functional pairs in healthy populations without known nutritional deficiencies to reduce the risk for cardiovascular disease or cancer. The USPSTF found adequate evidence that supplementation with ␤-carotene or vitamin E in healthy populations without known nutritional deficiencies does not reduce the risk for cardiovascular disease or cancer.
Harms of Vitamin Supplementation
The USPSTF found inadequate evidence on the harms of supplementation with multivitamins and most single vitamins or minerals or functional pairs. The USPSTF found adequate evidence that supplementation with ␤-carotene increases the risk for lung cancer in persons who are at increased risk for this condition. The USPSTF found adequate evidence that supplementation with vitamin E has few or no substantial harms.
USPSTF Assessment
The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of supplementation with multivitamins for the prevention of cardiovascular disease or cancer. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of supplementation with single or paired nutrients (except ␤-carotene or vitamin E) for the prevention of cardiovascular disease or cancer. The USPSTF concludes with moderate certainty that there is no net benefit of supplementation with vitamin E or ␤- 
Other Relevant USPSTF Recommendations

Balance of Benefits and Harms
Evidence on supplementation with multivitamins to reduce the risk for cardiovascular disease or cancer is inadequate, as is the evidence on supplementation with individual vitamins, minerals, or functional pairs. Supplementation with -carotene or vitamin E does not reduce the risk for cardiovascular disease or cancer.
The USPSTF has made several recommendations on the prevention of cardiovascular disease and cancer, including recommendations for smoking cessation; screening for lipid disorders, hypertension, diabetes, and cancer; obesity screening and counseling; and aspirin use. These recommendations are available at www.uspreventiveservicestaskforce.org.
Healthy adults without special nutritional needs.
This recommendation does not apply to children, women who are pregnant or may become pregnant, or persons who are chronically ill or hospitalized or have a known nutritional deficiency.
Multivitamins: No recommendation.
Grade: I statement
Single-or paired-nutrient supplements:
No recommendation.
Grade: I statement -Carotene or vitamin E:
Do not recommend.
Grade: D
The evidence is insufficient to determine the balance of benefits and harms of supplementation with multivitamins for the prevention of cardiovascular disease or cancer.
The evidence is insufficient to determine the balance of benefits and harms of supplementation with single or paired nutrients for the prevention of cardiovascular disease or cancer.
There is no net benefit of supplementation with vitamin E or -carotene for the prevention of cardiovascular disease or cancer.
For a summary of the evidence systematically reviewed in making this recommendation, the full recommendation statement, and supporting documents, please go to www.uspreventiveservicestaskforce.org.
carotene for the prevention of cardiovascular disease or cancer.
CLINICAL CONSIDERATIONS Patient Population Under Consideration
The focus of this recommendation is healthy adults without special nutritional needs. Populations studied were typically aged 50 years or older. This recommendation does not apply to children, women who are pregnant or may become pregnant, or persons who are chronically ill or hospitalized or have a known nutritional deficiency.
Suggestions for Practice Regarding the I Statements Potential Preventable Burden
Evidence from in vitro and animal research and population-based epidemiologic studies supports the hypothesis that oxidative stress may play a fundamental role in the initiation and progression of cancer and common cardiovascular diseases (3) . If this hypothesis is correct, then some combination of specific supplements, a specific dose, a vulnerable host, and specific timing may be found to be useful.
Potential Harms
Important harms have been shown with ␤-carotene in persons who smoke tobacco or have an occupational exposure to asbestos. There are several known adverse effects caused by excessive doses of vitamins; for example, moderate doses of vitamin A supplements may reduce bone mineral density, but high doses may be hepatotoxic or teratogenic. Otherwise, the vitamins reviewed by the USPSTF had few known risks. Because many of these vitamins are fat-soluble, the lifetime effect of high doses should be taken into consideration.
The USPSTF did not address doses higher than the tolerable upper intake level, as determined by the U.S. Food and Nutrition Board. Vitamins A and D have known harms at doses exceeding the tolerable upper intake levels (5) , and the potential for harm from other supplements at high doses should be carefully considered.
The U.S. Pharmacopeia has developed reference standards to aid in quality control of dietary supplement production; however, the content and concentration of ingredients in commercially available formulations probably vary considerably. This variability in the composition of dietary supplements makes extrapolating results obtained from controlled clinical trials challenging.
Costs
Although dietary supplements themselves are not particularly costly, the cumulative effect of this class of agent on spending is substantial. In 2010, $28.1 billion was spent on dietary supplements in the United States (6) .
Current Practice
Surveys conducted by the dietary supplement industry suggest that many physicians and nurses have recommended dietary supplements to their patients for health and wellness (7) .
Additional Approaches to Prevention
Appropriate intake of vitamin and mineral nutrients is essential to overall health (5) . Despite the uncertain benefit of vitamin supplementation, the 2010 Dietary Guidelines for Americans (8) suggest that nutrients come primarily from foods and provide guidance on how to consume a nutrient-rich diet. Adequate nutrition by eating a diet rich in fruits, vegetables, whole grains, fat-free and low-fat dairy products, and seafood has been associated with a reduced risk for cardiovascular disease and cancer (9, 10) .
Specific groups of patients with well-defined conditions may benefit from specific nutrients. For example, women who are planning to or may become pregnant should receive a daily supplement containing folic acid to help prevent neural tube defects. The USPSTF also recommends vitamin D supplements for older persons at risk for falling.
Useful Resources
The USPSTF has a large portfolio of recommendations for prevention of cardiovascular disease and cancer, including recommendations for smoking cessation; screening for lipid disorders, hypertension, diabetes, and cancer; obesity screening and counseling; and aspirin use (available at www.uspreventiveservicestaskforce.org).
OTHER CONSIDERATIONS Research Needs and Gaps
A critical gap in the evidence is the lack of studies of multivitamin combinations in groups generalizable to the U.S. population. Two randomized, controlled trials (RCTs) of multivitamin supplements suggest a potential cancer prevention benefit in men but not women. Future trials should be more representative of the general population, including women and minority groups, and should have enough power to show whether there are true subgroup differences. Targeting research toward persons who can be identified as high-risk for nutrient deficiency rather than the general population may be more productive.
There are substantial challenges to studying nutrient supplementation by using methods similar to those used in studying pharmaceutical interventions. New and innovative research methods for examining effects of nutrients that account for the unique complexities of nutritional research but maintain rigorous designs should be explored.
The paucity of studies and general lack of effect of any single nutrient or nutrient pair makes it difficult to draw meaningful conclusions on the balance of benefits and harms without a coordinated research effort and focus. A general lack of standardized methods to determine relevant Clinical Guideline Multivitamin Supplements for Cardiovascular Disease and Cancer serum nutrient levels, agreement on thresholds for sufficiency and insufficiency, or predictive validity of current mechanistic models further hinders progress in understanding potential benefits of dietary supplements.
DISCUSSION
Burden of Disease
Cardiovascular disease and cancer are the largest contributors to the burden of chronic disease in the developed world. In 2011, these diseases accounted for 23.7% and 22.8% of all deaths in the United States, respectively (11) .
Scope of Review
In order to update its 2003 recommendation, the USPSTF reviewed evidence of the efficacy of multivitamin or mineral supplements in the general adult population for the prevention of cardiovascular disease and cancer (3, 12) . The value of vitamins that naturally occur in food and the use of vitamin supplements for the prevention of other conditions (for example, neural tube defects) and for the secondary prevention of complications in patients with existing disease are outside the scope of this review.
Effectiveness of Preventive Medication
Multivitamin and Antioxidant Combinations
The USPSTF reviewed 4 RCTs and 1 cohort study assessing health outcomes of a multivitamin supplement (3) . The studies varied in the nutrients and doses used. No effect on all-cause mortality was found in the 3 trials that assessed this outcome. Two trials assessed cardiovascular disease outcomes. Overall, there was no effect on incidence of cardiovascular disease events. One trial reported a borderline significant decrease in fatal myocardial infarctions.
Two large trials, the Physicians' Health Study II (13) and the SU.VI.MAX (Supplementation in Vitamins and Mineral Antioxidants) study (14) , showed a decrease in overall cancer incidence in men (pooled unadjusted relative risk, 0.93 [95% CI, 0.87 to 0.99]) (3). The Physicians' Health Study II included 14 641 male U.S. physicians at an average age of 64.3 years. The intervention used a commercially available multivitamin that contained 30 ingredients. The unadjusted relative risk for total cancer incidence was 0.94 (CI, 0.87 to 1.00) after 11.2 years of follow-up. The homogeneity of this study population (primarily older white male physicians) limits its generalizability.
The SU.VI.MAX study was conducted in 13 017 men and women at an average age of 49 years in France. The intervention supplement included nutritional doses of vitamins C and E plus ␤-carotene, selenium, and zinc. Outcomes were reported for the end of the intervention phase at 7.5 years and again at 12.5 years after randomization. During the supplementation period, overall cancer incidence was not affected in women but decreased by 31% in men (adjusted relative risk, 0.69 [CI, 0.53 to 0.91]). The lack of effect in women and the use of different supple-ment formulations in the 2 trials make extrapolating these findings to the general population difficult.
Single and Paired Vitamins and Minerals
The USPSTF reviewed 24 studies of individual vitamins or minerals or functional nutrient pairs (3) . Across all of the supplements studied, there was no evidence of beneficial effect on cardiovascular disease, cancer, or all-cause mortality. However, the limited number of studies for most individual nutrients and differences in study designs make pooling effects across supplements difficult. Therefore, the USPSTF is not able to conclude with certainty that there is no effect. The evidence for each individual nutrient is discussed here.
Vitamin A. The USPSTF reviewed 3 RCTs and 2 cohort studies of vitamin A (3). None of the studies reported cardiovascular disease incidence. One good-quality trial showed an increased risk for lung cancer and related death. The baseline population (smokers and workers who had been exposed to asbestos) was at high risk for lung cancer, so the increased mortality may be attributable to the ␤-carotene component. Two trials reported all-cause mortality, but no significant difference was observed between intervention and control groups at the longest follow-up. Increased risk for hip fractures was observed in 1 large prospective cohort study of postmenopausal women.
Vitamin C. Two RCTs studied the effects of vitamin C, either alone or in combination with other supplements, and found no statistically significant effect on cardiovascular disease, cancer, or all-cause mortality (3).
Vitamin D With or Without Calcium. Three trials studied the effects of vitamin D on cardiovascular disease and cancer (3) . Two trials found no effect on cardiovascular disease incidence or mortality. One trial reported cancer incidence and death and found no difference between intervention and control groups. Two trials reporting allcause mortality found no statistically significant difference.
Two trials studied vitamin D and calcium combined. One small, fair-quality study found a statistically significant decreased risk for cancer with supplement use (15) . The WHI (Women's Health Initiative) trial, a larger, good-quality trial using lower doses of vitamin D and calcium supplements, found no effect on cancer incidence or mortality (16) . A post hoc subgroup analysis of women who were not receiving supplements at baseline showed an association between vitamin D and calcium supplements and lower total cancer and breast cancer incidence (17) .
Only the WHI trial reported cardiovascular disease incidence and mortality and all-cause mortality, and it found no effect after 7 years of follow-up. Four trials of calcium supplementation found no effect on overall cardiovascular disease, cancer, or all-cause mortality (3) . cidence and mortality. One trial in women reported a lower cardiovascular disease mortality in the intervention group, but mortality rates for myocardial infarction and stroke did not differ statistically. One trial found an increased risk for hemorrhagic stroke in the intervention group. Four RCTs reported cancer incidence. Overall, there was no significant effect on incidence of all types of cancer or on cancer mortality rates. No effect on all-cause mortality was observed in the 5 trials reporting this outcome.
Vitamin E was not found to have any effect on sitespecific cancer incidence, although the results for prostate cancer were mixed. The ATBC (Alpha-Tocopherol, Beta Carotene Cancer Prevention) study (18) reported a decreased incidence of prostate cancer, but the effect did not persist with longer follow-up. Conversely, SELECT (Selenium and Vitamin E Cancer Prevention Trial) (19) reported an increased risk for prostate cancer after extended follow-up.
␤-Carotene. A consistent body of evidence from 6 clinical trials suggests that ␤-carotene supplementation does not decrease the risk for cardiovascular disease events, overall cancer incidence, or cancer mortality (3) . Two trials, the ATBC study (18) and CARET (Carotene and Retinol Efficacy Trial) (20) , showed an increased risk for lung cancer incidence and mortality and all-cause mortality in participants with a high baseline risk for lung cancer. A metaanalysis of ␤-carotene trials reported an increased risk for lung cancer (pooled odds ratio, 1.24 [CI, 1.10 to 1.39]) in current smokers (21) .
Selenium. Two trials studied selenium alone or in combination with other nutrients and found no effect on cardiovascular disease or all-cause mortality (3) . The effect on cancer was mixed. One trial found a decrease in risk for cancer incidence and mortality; the other found no significant difference. Additional analyses showed a decrease in cancer incidence only in men with the lowest levels of selenium, suggesting a potential effect resulting from treatment of selenium deficiency. No differences in all-cause mortality were found in either trial.
Folic Acid. Only 1 trial studied folic acid (3) . It found no effect on cardiovascular disease incidence or all-cause mortality. There was an increased incidence of cancer, attributed to an excess number of deaths from prostate cancer in the intervention group.
Potential Harms of Preventive Medication
Overall, few significant harms were reported from these interventions except for ␤-carotene. As described previously, 2 trials reported increased risk for lung cancer and lung cancer mortality in smokers, especially heavy smokers. No trials observed an increased risk for cancer in nonsmokers.
The literature contains reports of less serious harms, such as hypercarotenemia or yellowing of the skin (multivitamins and ␤-carotene), rashes (multivitamins), minor bleeding events (multivitamins), and gastrointestinal symptoms (calcium and selenium). Rare but more serious harms were associated with some nutrient trials, including hip fractures (vitamin A), prostate cancer (folic acid), and kidney stones (vitamin D and calcium).
Estimate of Magnitude of Net Benefit
The USPSTF found inadequate evidence on the effectiveness of multivitamin supplements to prevent cardiovascular disease or cancer. Therefore, the USPSTF concludes that the evidence is lacking and the balance of benefits and harms cannot be determined. The USPSTF also found inadequate evidence on the effectiveness of supplementation with most single or paired vitamins or minerals and is therefore unable to determine the balance of benefits and harms of their use to prevent cardiovascular disease or cancer.
Only 2 vitamin supplements have sufficient data to estimate net benefit. ␤-Carotene has been associated with a statistically significant increased risk for lung cancer in smokers. The USPSTF concludes with moderate certainty that the net benefit of ␤-carotene supplementation is negative (that is, there is a net harm).
A large and consistent body of evidence has shown that vitamin E supplementation has no effect on cardiovascular disease, cancer, or all-cause mortality. The USPSTF concludes with moderate certainty that the net benefit of vitamin E supplementation is zero.
How Does Evidence Fit With Biological Understanding?
The risk factors for cardiovascular disease are wellestablished. Risk factors for cancer are considerably more complex because of the heterogeneous nature of different types of cancer and environmental and genetic influences. Inflammation, oxidative stress, and methionine metabolism have been theorized as common pathologic mechanisms for cardiovascular disease and cancer.
The potential antioxidant and anti-inflammatory effects of many nutrient supplements are the basis for their proposed use to prevent cardiovascular disease and cancer (3) . The oxidative properties of antioxidants are not fully understood; however, research has suggested that these properties may vary in relation to other factors, such as the concentration of the nutrient and presence of other oxidants or antioxidants. The harmful association between ␤-carotene and lung cancer suggests that other variables may influence whether ␤-carotene acts as an antioxidant versus a pro-oxidant.
Response to Public Comments
A draft version of this recommendation statement was posted for public comment on the USPSTF Web site from 12 November to 9 December 2013. In response to these comments, the USPSTF added language emphasizing that the harms of ␤-carotene were found in persons at increased risk for lung cancer. The discussion of vitamin E was revised to clarify the consistency of evidence showing a lack of benefit. Additional language was added to the Research Clinical Guideline Multivitamin Supplements for Cardiovascular Disease and Cancer Needs and Gaps section to highlight other challenges in nutrient research. The Recommendations of Others section was enhanced with recommendations from additional organizations.
UPDATE OF PREVIOUS USPSTF RECOMMENDATION
This recommendation updates the 2003 USPSTF recommendation on vitamin supplementation to prevent cardiovascular disease or cancer. At that time, the USPSTF concluded that the evidence was insufficient to recommend for or against supplements of vitamins A, C, or E; multivitamins with folic acid; or antioxidant combinations for the prevention of cardiovascular disease or cancer (I statement). The USPSTF also recommended against ␤carotene supplements, either alone or in combination with other supplements, for the prevention of cardiovascular disease or cancer (D recommendation).
In the current recommendation, the USPSTF considered evidence on additional nutrient supplements, including vitamin D, calcium, selenium, and folic acid, for the primary prevention of cardiovascular disease and cancer. New evidence on vitamin E increased the USPSTF's certainty about its lack of effectiveness in preventing these conditions.
RECOMMENDATIONS OF OTHERS
An independent consensus panel sponsored by the National Institutes of Health concluded that the present evidence is insufficient to recommend for or against multivitamins to prevent chronic disease (22). The Academy of Nutrition and Dietetics (formerly the American Dietetic Association) noted in a 2009 position statement that, although multivitamin supplements may be useful in meeting the recommended levels of some nutrients, there is no evidence that they are effective in preventing chronic disease (23) .
The American Cancer Society found that current evidence does not support the use of dietary supplements for the prevention of cancer (10) . The American Institute for Cancer Research determined in 2007 that dietary supplements are not recommended for cancer prevention and recommended a balanced diet with a variety of foods rather than supplements (24).
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